Facebook Instagram X-twitter Linkedin

BPC 10mg + TB 10mg (20mg)

Table of Contents

  • Quickstart Highlights

BPC 10mg + TB 10mg (20mg) combines two well-researched peptides—BPC-157 (Body Protection Compound) and Thymosin Beta-4 (TB-4)—known for their potential roles in tissue repair, recovery, and inflammation modulation. This synergistic blend is commonly explored for accelerating healing of muscles, tendons, ligaments, and soft tissues. This guide outlines a subcutaneous administration approach optimized for the 20 mg combined vial.

  • Reconstitute: Add 2.0 mL bacteriostatic water → 10 mg/mL combined concentration (5 mg/mL each peptide)
  • Typical daily range: 250–1000 mcg (0.25–1 mg) combined dose (subcutaneous)
  • Easy measuring: At 10 mg/mL, 1 unit = 0.01 mL = 100 mcg (0.1 mg) total peptides
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks
  • Protocol Overview

Concise summary of the subcutaneous regimen.

  • Goal: Support recovery, tissue repair, and inflammation balance
  • Schedule: Daily subcutaneous injections; may be split into multiple doses
  • Dose Range: 250–1000 mcg per day (combined)
  • Cycle Length: Commonly used in 2–6 week cycles, depending on recovery needs
  • Dosing Protocol

Suggested approach for the 20 mg combined vial.

  • Start: 250–500 mcg once daily to assess tolerance
  • Target: 500–1000 mcg per day, split into 1–2 doses if needed
  • Frequency: Once or twice daily (subcutaneous)
  • Vial Duration: One 20 mg vial lasts approximately 20–80 days, depending on dose
  • Timing: Flexible; often administered near injury site or before/after activity
  • Mechanism of Action

BPC-157 is a synthetic peptide derived from a protective protein found in gastric juice. It has been studied for its ability to promote angiogenesis (formation of new blood vessels), collagen synthesis, and tissue regeneration. It may also support gut health and reduce inflammation.

Thymosin Beta-4 (TB-4) is a naturally occurring peptide involved in cell migration, wound healing, and tissue repair. It plays a role in actin regulation, which is essential for cell movement and regeneration processes.

When combined, BPC-157 and TB-4 may provide complementary effects—enhancing cellular repair pathways, improving blood flow to injured areas, and supporting faster recovery of damaged tissues. This synergy is why the combination is commonly explored in recovery-focused protocols.

  • Potential Benefits & Side Effects

Observations based on preclinical and early-stage research.

Potential Benefits:

  • May accelerate healing of muscles, tendons, and ligaments
  • May reduce inflammation and support injury recovery
  • Potential improvement in joint health and mobility
  • May support gut repair and overall tissue regeneration

Possible Side Effects:

  • Generally well tolerated in research settings
  • Mild injection-site irritation or redness
  • Occasional fatigue or lightheadedness
  • Long-term human safety data remain limited; investigational use only